Dhruva Biswas
Dhruva Biswas
UCL Cancer Institute & Francis Crick Institute
Verified email at
Cited by
Cited by
Meta-analysis of tumor-and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
K Litchfield, JL Reading, C Puttick, K Thakkar, C Abbosh, R Bentham, ...
Cell 184 (3), 596-614. e14, 2021
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ...
The Lancet 396 (10246), e6-e7, 2020
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ...
Nature medicine 25 (10), 1534-1539, 2019
Metastasis and immune evasion from extracellular cGAMP hydrolysis
J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ...
Cancer discovery 11 (5), 1212-1227, 2021
An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
Y Wu, F Kyle-Cezar, RT Woolf, C Naceur-Lombardelli, J Owen, D Biswas, ...
Science translational medicine 11 (513), eaax9364, 2019
A clonal expression biomarker associates with lung cancer mortality
D Biswas, NJ Birkbak, R Rosenthal, CT Hiley, EL Lim, K Papp, S Boeing, ...
Nature medicine 25 (10), 1540-1548, 2019
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
E Ghorani, JL Reading, JY Henry, MR Massy, R Rosenthal, V Turati, ...
Nature cancer 1 (5), 546-561, 2020
The evolution of lung cancer and impact of subclonal selection in TRACERx
AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ...
Nature 616 (7957), 525-533, 2023
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ...
Nature 616 (7957), 553-562, 2023
Scalable and robust SARS-CoV-2 testing in an academic center
J Aitken, K Ambrose, S Barrell, R Beale, G Bineva-Todd, D Biswas, ...
Nature biotechnology 38 (8), 927-931, 2020
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
Y Wu, D Biswas, I Usaite, M Angelova, S Boeing, T Karasaki, S Veeriah, ...
Nature cancer 3 (6), 696-709, 2022
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
T Karasaki, DA Moore, S Veeriah, C Naceur-Lombardelli, A Toncheva, ...
Nature medicine 29 (4), 833-845, 2023
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Y Wu, D Biswas, C Swanton
Seminars in cancer biology 84, 89-102, 2022
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
P East, GP Kelly, D Biswas, M Marani, DC Hancock, T Creasy, ...
Nature communications 13 (1), 5632, 2022
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy
S Balestrini, MJ Koepp, S Gandhi, HM Rickman, GY Shin, CF Houlihan, ...
Epilepsy & Behavior 115, 107602, 2021
The future of liquid biopsy
D Biswas, J Ganeshalingam, JCM Wan
The Lancet Oncology 21 (12), e550, 2020
Artificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction
J Wu, D Biswas, M Ryan, BS Bernstein, M Rizvi, N Fairhurst, G Kaye, ...
European Journal of Heart Failure 26 (2), 302-310, 2024
PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy
D Davies, S Kamdar, R Woolf, I Zlatareva, ML Iannitto, C Morton, Y Haque, ...
Nature Cancer, 1-13, 2024
Tracing evolution reveals new biomarkers
P Sidaway
Nature Reviews Clinical Oncology 17 (1), 5-5, 2020
The system can't perform the operation now. Try again later.
Articles 1–20